Inicio
Información del autor
Autor Carolina Prieto Saldarriaga
Comentario :
Médica Internista Endocrinóloga, Hospital Pablo Tobón Uribe
|
Documentos disponibles escritos por este autor (8)
Clasificado(s) por (Año de edición descendente) Refinar búsqueda
Título : Complejo de Carney: reporte de un caso y revisión de la literatura Otros títulos : Carney complex: a case report and literature review Tipo de documento : documento electrónico Autores : Carolina Prieto Saldarriaga, Fecha de publicación : 2022 Títulos uniformes : Iatreia Idioma : Español (spa) Palabras clave : acromegalia complejo de Carney mixoma schwannomas síndrome de Cushing Resumen : El complejo de Carney es una enfermedad caracterizada por lesiones en la piel, tumores endocrinos, ardiacos, gonadales y en otros órganos, que está asociada con mutaciones del gen PRKAR1A. Presentamos el caso clínico de una paciente con varias de las manifestaciones más características de este síndrome. Finalmente, se hace una revisión de la literatura. Mención de responsabilidad : Johnayro Gutiérrez-Restrepo, Carolina Aguilar-Londoño, Carolina Prieto-Saldarriaga DOI (Digital Object Identifier) : 10.17533/udea.iatreia.123 Derechos de uso : CC BY-NC-SA En línea : https://revistas.udea.edu.co/index.php/iatreia/article/view/346628 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=6096 Complejo de Carney: reporte de un caso y revisión de la literatura = Carney complex: a case report and literature review [documento electrónico] / Carolina Prieto Saldarriaga, . - 2022.
Obra : Iatreia
Idioma : Español (spa)
Palabras clave : acromegalia complejo de Carney mixoma schwannomas síndrome de Cushing Resumen : El complejo de Carney es una enfermedad caracterizada por lesiones en la piel, tumores endocrinos, ardiacos, gonadales y en otros órganos, que está asociada con mutaciones del gen PRKAR1A. Presentamos el caso clínico de una paciente con varias de las manifestaciones más características de este síndrome. Finalmente, se hace una revisión de la literatura. Mención de responsabilidad : Johnayro Gutiérrez-Restrepo, Carolina Aguilar-Londoño, Carolina Prieto-Saldarriaga DOI (Digital Object Identifier) : 10.17533/udea.iatreia.123 Derechos de uso : CC BY-NC-SA En línea : https://revistas.udea.edu.co/index.php/iatreia/article/view/346628 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=6096 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001944 AC-2022-105 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
AC-2022-105Adobe Acrobat PDFInsulinoma-related endogenous hypoglycaemia with a negative fasting test: a case report and literature review / Carolina Prieto Saldarriaga ; Carlos Esteban Builes Montaño ; Clara María Arango Toro
Título : Insulinoma-related endogenous hypoglycaemia with a negative fasting test: a case report and literature review Tipo de documento : documento electrónico Autores : Carolina Prieto Saldarriaga, ; Carlos Esteban Builes Montaño, ; Clara María Arango Toro, Fecha de publicación : 2022 Títulos uniformes : European Journal of Case Reports in Internal Medicine Idioma : Inglés (eng) Palabras clave : Insulinoma hyperinsulinaemia fasting Resumen : We present the case of a patient with a history of symptomatic hypoglycaemic episodes and a negative 72-hour fasting test with histological confirmation of insulinoma. A literature review of hyperinsulinaemic hypoglycaemia with a negative fasting test was performed. Mención de responsabilidad : Carolina Prieto-Saldarriaga, Carlos Esteban Builes-Montaño, Clara María Arango-Toro, Cindy Manotas-Echeverry, Juan Camilo Pérez-Cadavid, José C Álvarez-Payares, Luis Antonio Rodríguez-Arrieta Referencia : Eur J Case Rep Intern Med. 2022 Sep 9;9(9):003484. DOI (Digital Object Identifier) : 10.12890/2022_003484 PMID : 36299851 En línea : https://www.ejcrim.com/index.php/EJCRIM/article/view/3484 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=6105 Insulinoma-related endogenous hypoglycaemia with a negative fasting test: a case report and literature review [documento electrónico] / Carolina Prieto Saldarriaga, ; Carlos Esteban Builes Montaño, ; Clara María Arango Toro, . - 2022.
Obra : European Journal of Case Reports in Internal Medicine
Idioma : Inglés (eng)
Palabras clave : Insulinoma hyperinsulinaemia fasting Resumen : We present the case of a patient with a history of symptomatic hypoglycaemic episodes and a negative 72-hour fasting test with histological confirmation of insulinoma. A literature review of hyperinsulinaemic hypoglycaemia with a negative fasting test was performed. Mención de responsabilidad : Carolina Prieto-Saldarriaga, Carlos Esteban Builes-Montaño, Clara María Arango-Toro, Cindy Manotas-Echeverry, Juan Camilo Pérez-Cadavid, José C Álvarez-Payares, Luis Antonio Rodríguez-Arrieta Referencia : Eur J Case Rep Intern Med. 2022 Sep 9;9(9):003484. DOI (Digital Object Identifier) : 10.12890/2022_003484 PMID : 36299851 En línea : https://www.ejcrim.com/index.php/EJCRIM/article/view/3484 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=6105 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001953 AC-2022-114 Archivo digital Producción Científica Artículos científicos Disponible 
Título : Late systemic lupus erythematosus-associated insulin resistance syndrome: a rare cause of de novo diabetes mellitus Tipo de documento : documento electrónico Autores : Carlos Esteban Builes Montaño, ; Carolina Prieto Saldarriaga, ; Clara María Arango Toro, ; Juan Guillermo Gamboa Arroyave, Fecha de publicación : 2022 Títulos uniformes : Case Reports in Medicine Idioma : Inglés (eng) Resumen : The association of type B insulin resistance syndrome (TBIRS) due to autoimmune diseases such as systemic lupus erythematosus (SLE) is uncommon. This is partly due to the lack of established criteria for the diagnosis of this resistance. However, some clinical aspects may suggest that the diagnosis does not necessarily have to be positive insulin receptor antibodies as such patients could respond to immunosuppressive treatment. Methods. We describe a case and have performed a literature review on PubMed/MEDLINE, EMBASE, and Google Scholar bibliographic databases to identify all case reports. All available studies from January 1975 through December 2020 were included. Data collected were tabulated, and outcomes were analyzed cumulatively. Results. Thirty-one cases of TBIRS associated with SLE have been described. These patients presented with catabolic symptoms and hyperglycemia in most cases, with an average time from the onset of symptoms of four months. In addition to that clinical characteristics related to SLE were variable, along with certain common characteristics such as acanthosis in 60% of patients. Almost all the patients had antibodies against insulin receptors. The insulin doses required by the patients ranged from 450 to 25,000 U daily. Remission was achieved in 80% of the patients with a two-year follow-up. Most patients associated with late-onset SLE, like our patient, achieved metabolic control after immunosuppressive treatment. Conclusion. High insulin resistance in patients with de novo diabetes mellitus (DM) without obesity should be considered as a possible clinical manifestation of an autoimmune disease such as SLE, with a good metabolic response to the immunosuppressive management established. Mención de responsabilidad : José C Alvarez-Payares, Daniel Ribero, Luis Rodríguez, Carlos E Builes, Carolina Prieto, Clara Arango, Juan G Gamboa, Cristian Alvarez-Payares Referencia : Case Rep Med. 2022 Oct 14;2022:4655804. DOI (Digital Object Identifier) : 10.1155/2022/4655804 PMID : 36275943 Derechos de uso : CC BY En línea : https://www.hindawi.com/journals/crim/2022/4655804/ Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=6075 Late systemic lupus erythematosus-associated insulin resistance syndrome: a rare cause of de novo diabetes mellitus [documento electrónico] / Carlos Esteban Builes Montaño, ; Carolina Prieto Saldarriaga, ; Clara María Arango Toro, ; Juan Guillermo Gamboa Arroyave, . - 2022.
Obra : Case Reports in Medicine
Idioma : Inglés (eng)
Resumen : The association of type B insulin resistance syndrome (TBIRS) due to autoimmune diseases such as systemic lupus erythematosus (SLE) is uncommon. This is partly due to the lack of established criteria for the diagnosis of this resistance. However, some clinical aspects may suggest that the diagnosis does not necessarily have to be positive insulin receptor antibodies as such patients could respond to immunosuppressive treatment. Methods. We describe a case and have performed a literature review on PubMed/MEDLINE, EMBASE, and Google Scholar bibliographic databases to identify all case reports. All available studies from January 1975 through December 2020 were included. Data collected were tabulated, and outcomes were analyzed cumulatively. Results. Thirty-one cases of TBIRS associated with SLE have been described. These patients presented with catabolic symptoms and hyperglycemia in most cases, with an average time from the onset of symptoms of four months. In addition to that clinical characteristics related to SLE were variable, along with certain common characteristics such as acanthosis in 60% of patients. Almost all the patients had antibodies against insulin receptors. The insulin doses required by the patients ranged from 450 to 25,000 U daily. Remission was achieved in 80% of the patients with a two-year follow-up. Most patients associated with late-onset SLE, like our patient, achieved metabolic control after immunosuppressive treatment. Conclusion. High insulin resistance in patients with de novo diabetes mellitus (DM) without obesity should be considered as a possible clinical manifestation of an autoimmune disease such as SLE, with a good metabolic response to the immunosuppressive management established. Mención de responsabilidad : José C Alvarez-Payares, Daniel Ribero, Luis Rodríguez, Carlos E Builes, Carolina Prieto, Clara Arango, Juan G Gamboa, Cristian Alvarez-Payares Referencia : Case Rep Med. 2022 Oct 14;2022:4655804. DOI (Digital Object Identifier) : 10.1155/2022/4655804 PMID : 36275943 Derechos de uso : CC BY En línea : https://www.hindawi.com/journals/crim/2022/4655804/ Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=6075 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001919 AC-2022-083 Archivo digital Producción Científica Artículos científicos Disponible Documentos electrónicos
AC-2022-083Adobe Acrobat PDF
Título : Therapeutic plasmapheresis for the treatment of thyrotoxicosis: A retrospective multi-center study Tipo de documento : documento electrónico Autores : Carlos Esteban Builes Montaño, ; Carolina Prieto Saldarriaga, ; Clara María Arango Toro, Fecha de publicación : 2021 Títulos uniformes : Journal of Clinical Apheresis Idioma : Inglés (eng) Palabras clave : anti-thyroid agents hyperthyroidism Latin America plasmapheresis thyrotoxicosis Resumen : Background and aims: Thyroid storm and severe thyrotoxicosis remain among the most frequent endocrine emergencies, and first-line hyperthyroidism treatment is not always an option. Since the first report in 1970, plasmapheresis is a second-line treatment for severe or otherwise untreatable thyrotoxicosis when rapid euthyroidism is desired. Methods: We present a retrospective study of the experience in treating thyrotoxicosis with plasmapheresis between 2012 and 2020 in two specialized centers in Colombia. We register the demographic and clinical characteristic and compare the thyroid hormones and other biochemical measurements before and after treatment. Results: Data from 19 patients was obtained, 58% female with a median age of 35 years (IQR 23.5), and most of them with Graves' disease. The most frequent indication for plasmapheresis was thyroid storm. A median of 4 (IQR 2) sessions lead to a significant reduction in FT4 (P .0001) and TT3 (P Mención de responsabilidad : Carlos E. Builes-Montaño,Luis A. Rodriguez-Arrieta,Alejandro Román-González,Carolina Prieto-Saldarriaga,Jose C. Alvarez-Payares,Carlos A. Builes-Barrera,Clara M. Arango-Toro Referencia : J Clin Apher. 2021 Oct;36(5):759-765. DOI (Digital Object Identifier) : 10.1002/jca.21927 PMID : 34273178 En línea : https://onlinelibrary.wiley.com/doi/10.1002/jca.21927 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5818 Therapeutic plasmapheresis for the treatment of thyrotoxicosis: A retrospective multi-center study [documento electrónico] / Carlos Esteban Builes Montaño, ; Carolina Prieto Saldarriaga, ; Clara María Arango Toro, . - 2021.
Obra : Journal of Clinical Apheresis
Idioma : Inglés (eng)
Palabras clave : anti-thyroid agents hyperthyroidism Latin America plasmapheresis thyrotoxicosis Resumen : Background and aims: Thyroid storm and severe thyrotoxicosis remain among the most frequent endocrine emergencies, and first-line hyperthyroidism treatment is not always an option. Since the first report in 1970, plasmapheresis is a second-line treatment for severe or otherwise untreatable thyrotoxicosis when rapid euthyroidism is desired. Methods: We present a retrospective study of the experience in treating thyrotoxicosis with plasmapheresis between 2012 and 2020 in two specialized centers in Colombia. We register the demographic and clinical characteristic and compare the thyroid hormones and other biochemical measurements before and after treatment. Results: Data from 19 patients was obtained, 58% female with a median age of 35 years (IQR 23.5), and most of them with Graves' disease. The most frequent indication for plasmapheresis was thyroid storm. A median of 4 (IQR 2) sessions lead to a significant reduction in FT4 (P .0001) and TT3 (P Mención de responsabilidad : Carlos E. Builes-Montaño,Luis A. Rodriguez-Arrieta,Alejandro Román-González,Carolina Prieto-Saldarriaga,Jose C. Alvarez-Payares,Carlos A. Builes-Barrera,Clara M. Arango-Toro Referencia : J Clin Apher. 2021 Oct;36(5):759-765. DOI (Digital Object Identifier) : 10.1002/jca.21927 PMID : 34273178 En línea : https://onlinelibrary.wiley.com/doi/10.1002/jca.21927 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=5818 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001752 AC-2021-068 Archivo digital Producción Científica Artículos científicos Disponible
Título : Late diagnosis of pseudohypoparathyroidism in adulthood. Case series Otros títulos : Pseudohipoparatiroidismo diagnosticado tardíamente en la adultez, una serie de casos Tipo de documento : documento electrónico Autores : Clara María Arango Toro, ; Carolina Prieto Saldarriaga, Fecha de publicación : 2018 Títulos uniformes : Revista de la Facultad de Medicina Idioma : Inglés (eng) Palabras clave : Pseudohypoparathyroidism Parathyroid Diseases Hypocalcemia hyperphosphatemia Resumen : Introduction: Pseudohypoparathyroidism (PHP) is a rare hereditary disease, characterized by hypocalcemia/hyperphosphatemia secondary to peripheral resistance to parathyroid hormone (PTH). PHP diagnosis is usually precluded since hypocalcemia is considered as the primary diagnosis, thus delaying further diagnostic studies and preventing an adequate management of this clinical condition. Materials and methods: Retrospective review of the databases of the Endocrinology departments of two tertiary care centers of Medellin, Colombia from January 2012 to December 2016. Patients diagnosed with PHP based on clinical presentation and confirmatory laboratory values were included. Results: Four patients met the inclusion criteria. All PHP cases were diagnosed in adulthood despite strong early clinical and laboratory evidence of the disease. Three patients were diagnosed with Fahr’s syndrome and two with Albright’s hereditary osteodystrophy. The mean values obtained were PTH of 376.8 pg/mL, calcium of 6.17 mg/dL and phosphorus of 6.55 mg/dL. Conclusions: PHP is a rare disorder. This paper describes four PHP cases diagnosed during adulthood. Emphasis should be placed on the judicious approach to the patient with hypocalcemia and hyperphosphatemia with increased PTH and normal renal function, since these symptoms strongly suggest a diagnosis of PHP. Mención de responsabilidad : Maria Camila Trejo, Alejandro Roman-Gonzalez, Sebastian Ruiz, Catalina Tobón, Pablo Castaño, Clara Arango, Carolina Prieto DOI (Digital Object Identifier) : 10.15446/revfacmed.v66n4.66940 En línea : https://revistas.unal.edu.co/index.php/revfacmed/article/view/66940 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4700 Late diagnosis of pseudohypoparathyroidism in adulthood. Case series = Pseudohipoparatiroidismo diagnosticado tardíamente en la adultez, una serie de casos [documento electrónico] / Clara María Arango Toro, ; Carolina Prieto Saldarriaga, . - 2018.
Obra : Revista de la Facultad de Medicina
Idioma : Inglés (eng)
Palabras clave : Pseudohypoparathyroidism Parathyroid Diseases Hypocalcemia hyperphosphatemia Resumen : Introduction: Pseudohypoparathyroidism (PHP) is a rare hereditary disease, characterized by hypocalcemia/hyperphosphatemia secondary to peripheral resistance to parathyroid hormone (PTH). PHP diagnosis is usually precluded since hypocalcemia is considered as the primary diagnosis, thus delaying further diagnostic studies and preventing an adequate management of this clinical condition. Materials and methods: Retrospective review of the databases of the Endocrinology departments of two tertiary care centers of Medellin, Colombia from January 2012 to December 2016. Patients diagnosed with PHP based on clinical presentation and confirmatory laboratory values were included. Results: Four patients met the inclusion criteria. All PHP cases were diagnosed in adulthood despite strong early clinical and laboratory evidence of the disease. Three patients were diagnosed with Fahr’s syndrome and two with Albright’s hereditary osteodystrophy. The mean values obtained were PTH of 376.8 pg/mL, calcium of 6.17 mg/dL and phosphorus of 6.55 mg/dL. Conclusions: PHP is a rare disorder. This paper describes four PHP cases diagnosed during adulthood. Emphasis should be placed on the judicious approach to the patient with hypocalcemia and hyperphosphatemia with increased PTH and normal renal function, since these symptoms strongly suggest a diagnosis of PHP. Mención de responsabilidad : Maria Camila Trejo, Alejandro Roman-Gonzalez, Sebastian Ruiz, Catalina Tobón, Pablo Castaño, Clara Arango, Carolina Prieto DOI (Digital Object Identifier) : 10.15446/revfacmed.v66n4.66940 En línea : https://revistas.unal.edu.co/index.php/revfacmed/article/view/66940 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4700 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD001174 AC-2018-114 Archivo digital Producción Científica Artículos científicos Disponible PermalinkPermalinkPermalink
